The C-terminal sequence of IFITM1 regulates its anti-HIV-1 activity

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Jia, Rui ^a,b,e   Ding, Shilei ^b,c   Pan, Qinghua ^b   Liu, Shan Lu ^d   Qiao, Wentao ^a   Liang, Chen ^b,c  

^a NANKAI UNIVERSITY   (China)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d University of Missouri   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON INDUCIBLE TRANSMEMBRANE 1 PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIFFERENTIATION ANTIGEN; LEU-13 ANTIGEN;

ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; DELETION MUTANT; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 (STRAIN BH10); HUMAN IMMUNODEFICIENCY VIRUS 1 (STRAIN NL4.3); MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VIRUS ENTRY; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSMISSION; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENE DELETION; GENETICS; HEK293 CELL LINE; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SPECIES DIFFERENCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ANIMALS; ANTI-HIV AGENTS; ANTIGENS, DIFFERENTIATION; HEK293 CELLS; HIV-1; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION; SPECIES SPECIFICITY; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84928923360     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118794     Document Type: Article

References (41)

1. Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014; 32: 513-545. doi: 10.1146/annurev-immunol-032713-120231 PMID: 24555472
2. Lewin AR, Reid LE, McMahon M, Stark GR, Kerr IM. Molecular analysis of a human interferon-inducible gene family. Eur J Biochem. 1991; 199: 417-423. PMID: 1906403
3. Martensen PM, Justesen J. Small ISGs coming forward. J Interferon Cytokine Res. 2004; 24: 1-19. PMID: 14980080
4. Alber D, Staeheli P. Partial inhibition of vesicular stomatitis virus by the interferon-induced human 9-27 protein. J Interferon Cytokine Res. 1996; 16: 375-380. PMID: 8727077
5. Zhu H, Liu C. Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway. J Virol. 2003; 77: 5493-5498. PMID: 12692250
6. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell. 2009; 139: 1243-1254. doi: 10.1016/j.cell.2009.12.017 PMID: 20064371
7. Mudhasani R, Tran JP, Retterer C, Radoshitzky SR, Kota KP, Altamura LA, et al. IFITM-2 and IFITM-3 but Not IFITM-1 Restrict Rift Valley Fever Virus. J Virol. 2013; 87: 8451-8464. doi: 10.1128/JVI.03382-12 PMID: 23720721
8. Weidner JM, Jiang D, Pan XB, Chang J, Block TM, Guo JT. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol. 2010; 84: 12646-12657. doi: 10.1128/JVI.01328-10 PMID: 20943977
9. Jiang D, Weidner JM, Qing M, Pan XB, Guo H, Xu C, et al. Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol. 2010; 84: 8332-8341. doi: 10.1128/JVI.02199-09 PMID: 20534863
10. Lu J, Pan Q, Rong L, He W, Liu SL, Liang C. The IFITM proteins inhibit HIV-1 infection. J Virol. 2011; 85: 2126-2137. doi: 10.1128/JVI.01531-10 PMID: 21177806
11. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 2011; 7: e1001258. doi: 10.1371/journal.ppat.1001258 PMID: 21253575
12. Anafu AA, Bowen CH, Chin CR, Brass AL, Holm GH. Interferon Inducible Transmembrane Protein 3 (IFITM3) Restricts Reovirus Cell Entry. J Biol Chem. 2013; 288: 17261-17271. doi: 10.1074/jbc.M112.438515 PMID: 23649619
13. Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M, et al. IFITM Proteins Restrict Viral Membrane Hemifusion. PLoS Pathog. 2013; 9: e1003124. doi: 10.1371/journal.ppat.1003124 PMID: 23358889
14. Diamond MS, Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol. 2013; 13: 46-57. doi: 10.1038/nri3344 PMID: 23237964
15. Perreira JM, Chin CR, Feeley EM, Brass AL. IFITMs restrict the replication of multiple pathogenic viruses. J Mol Biol. 2013; 425: 4937-4955. doi: 10.1016/j.jmb.2013.09.024 PMID: 24076421
16. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature. 2012; 484: 519-523. doi: 10.1038/nature10921 PMID: 22446628
17. Bailey CC, Huang IC, Kam C, Farzan M. Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog. 2012; 8: e1002909. doi: 10.1371/journal.ppat.1002909 PMID: 22969429
18. Wakim LM, Gupta N, Mintern JD, Villadangos JA. Enhanced survival of lung tissue-resident memory CD8(+) T cells during infection with influenza virus due to selective expression of IFITM3. Nat Immunol. 2013; 14: 238-245. doi: 10.1038/ni.2525 PMID: 23354485
19. Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun. 2013; 4: 1418. doi: 10.1038/ncomms2433 PMID: 23361009
20. Sallman Almen M, Bringeland N, Fredriksson R, Schioth HB. The dispanins: a novel gene family of ancient origin that contains 14 human members. PLoS One. 2012; 7: e31961. doi: 10.1371/journal.pone.0031961 PMID: 22363774
21. Siegrist F, Ebeling M, Certa U. The small interferon-induced transmembrane genes and proteins. J Interferon Cytokine Res. 2011; 31: 183-197. doi: 10.1089/jir.2010.0112 PMID: 21166591
22. Moffatt P, Gaumond MH, Salois P, Sellin K, Bessette MC, Godin E, et al. Bril: a novel bone-specific modulator of mineralization. J Bone Miner Res. 2008; 23: 1497-1508. doi: 10.1359/jbmr.080412 PMID: 18442316
23. Samarajiwa SA, Forster S, Auchettl K, Hertzog PJ. INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res. 2009; 37: D852-857. doi: 10.1093/nar/gkn732 PMID: 18996892
24. Andreu P, Colnot S, Godard C, Laurent-Puig P, Lamarque D, Kahn A, et al. Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res. 2006; 66: 1949-1955. PMID: 16488993
25. Hickford DE, Frankenberg SR, Shaw G, Renfree MB. Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genomics. 2012; 13: 155. doi: 10.1186/1471-2164-13-155 PMID: 22537233
26. Tang BL, Wong SH, Low SH, Hong W. Retention of a type II surface membrane protein in the endoplasmic reticulum by the Lys-Asp-Glu-Leu sequence. J Biol Chem. 1992; 267: 7072-7076. PMID: 1348058
27. Ding S, Pan Q, Liu SL, Liang C. HIV-1 mutates to evade IFITM1 restriction. Virology. 2014; 454-455: 11-24. doi: 10.1016/j.virol.2014.01.020 PMID: 24725927
28. Le Tortorec A, Neil SJ. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J Virol. 2009; 83: 11966-11978. doi: 10.1128/JVI.01515-09 PMID: 19740980
29. Yu D, Wang W, Yoder A, Spear M, Wu Y. The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells. PLoS Pathog. 2009; 5: e1000633. doi: 10.1371/journal.ppat.1000633 PMID: 19851458
30. Yoder A, Yu D, Dong L, Iyer SR, Xu X, Kelly J, et al. HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. Cell. 2008; 134: 782-792. doi: 10.1016/j.cell.2008.06.036 PMID: 18775311
31. Sattentau Q. Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol. 2008; 6: 815-826. doi: 10.1038/nrmicro1972 PMID: 18923409
32. Zhao X, Guo F, Liu F, Cuconati A, Chang J, Block TM, et al. Interferon induction of IFITM proteins promotes infection by human coronavirus OC43. Proc Natl Acad Sci U S A. 2014; 111: 6756-6761. doi: 10.1073/pnas.1320856111 PMID: 24753610
33. Blumenthal R, Durell S, Viard M. HIV entry and envelope glycoprotein-mediated fusion. J Biol Chem. 2012; 287: 40841-40849. doi: 10.1074/jbc.R112.406272 PMID: 23043104
34. Vazquez-Calvo A, Saiz JC, McCullough KC, Sobrino F, Martin-Acebes MA. Acid-dependent viral entry. Virus Res. 2012; 167: 125-137. doi: 10.1016/j.virusres.2012.05.024 PMID: 22683298
35. Jia R, Pan Q, Ding S, Rong L, Liu SL, Geng Y, et al. The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J Virol. 2012; 86: 13697-13707. doi: 10.1128/JVI.01828-12 PMID: 23055554
36. Jia R, Xu F, Qian J, Yao Y, Miao C, Zheng YM, et al. Identification of an endocytic signal essential for the antiviral action of IFITM3. Cell Microbiol. 2014; 16:1080-1093. doi: 10.1111/cmi.12262 PMID: 24521078
37. Chesarino NM, McMichael TM, Hach JC, Yount JS. Phosphorylation of the antiviral protein interferoninducible transmembrane protein 3 (IFITM3) dually regulates its endocytosis and ubiquitination. J Biol Chem. 2014; 289: 11986-11992. doi: 10.1074/jbc.M114.557694 PMID: 24627473
38. John SP, Chin CR, Perreira J, Feeley EM, Aker A, Savidis G, et al. The CD225 Domain of IFITM3 is Required for both IFITM Protein Association and Inhibition of Influenza A Virus and Dengue Virus Replication. J Virol. 2013; 87: 7837-7852. doi: 10.1128/JVI.00481-13 PMID: 23658454
39. Weston S, Czieso S, White IJ, Smith SE, Kellam P, Marsh M. A membrane topology model for human interferon inducible transmembrane protein 1. PLoS One. 2014; 9: e104341. doi: 10.1371/journal.pone.0104341 PMID: 25105503
40. Levy DN, Aldrovandi GM, Kutsch O, Shaw GM. Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci U S A. 2004; 101: 4204-4209. PMID: 15010526
41. Cavrois M, De Noronha C, Greene WC. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol. 2002; 20: 1151-1154. PMID: 12355096